vs
Side-by-side financial comparison of FARMERS NATIONAL BANC CORP (FMNB) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $71.5M, roughly 1.1× FARMERS NATIONAL BANC CORP). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 3.2%). FARMERS NATIONAL BANC CORP produced more free cash flow last quarter ($52.2M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 6.2%).
Farmers National Banc Corp (OH) is a regional financial holding company based in Ohio, the United States. It offers full-spectrum retail and commercial banking products, wealth management solutions, and insurance services, primarily catering to individual consumers, small and medium-sized enterprises, and local community clients in Ohio and adjacent Midwestern U.S. regions.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
FMNB vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $71.5M | $75.5M |
| Net Profit | $14.6M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | 24.8% | 22.7% |
| Net Margin | 20.5% | — |
| Revenue YoY | 3.2% | 27.7% |
| Net Profit YoY | 1.7% | — |
| EPS (diluted) | $0.39 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $71.5M | $75.5M | ||
| Q3 25 | $70.8M | $54.5M | ||
| Q2 25 | $69.8M | $52.4M | ||
| Q1 25 | $67.8M | $46.0M | ||
| Q4 24 | $69.3M | $59.1M | ||
| Q3 24 | $70.3M | $80.5M | ||
| Q2 24 | $66.5M | $47.1M | ||
| Q1 24 | $63.4M | $43.8M |
| Q4 25 | $14.6M | — | ||
| Q3 25 | $12.5M | $8.8M | ||
| Q2 25 | $13.9M | $5.9M | ||
| Q1 25 | $13.6M | $3.0M | ||
| Q4 24 | $14.4M | — | ||
| Q3 24 | $8.5M | $20.3M | ||
| Q2 24 | $11.8M | $-4.5M | ||
| Q1 24 | $11.2M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | 24.8% | 22.7% | ||
| Q3 25 | 20.7% | 17.6% | ||
| Q2 25 | 23.4% | 12.7% | ||
| Q1 25 | 24.1% | 8.7% | ||
| Q4 24 | 25.5% | 22.6% | ||
| Q3 24 | 14.4% | 27.4% | ||
| Q2 24 | 21.3% | -4.6% | ||
| Q1 24 | 21.2% | -5.3% |
| Q4 25 | 20.5% | — | ||
| Q3 25 | 17.6% | 16.2% | ||
| Q2 25 | 19.9% | 11.2% | ||
| Q1 25 | 20.0% | 6.5% | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | 12.1% | 25.2% | ||
| Q2 24 | 17.7% | -9.6% | ||
| Q1 24 | 17.7% | -11.0% |
| Q4 25 | $0.39 | $0.26 | ||
| Q3 25 | $0.33 | $0.17 | ||
| Q2 25 | $0.37 | $0.12 | ||
| Q1 25 | $0.36 | $0.06 | ||
| Q4 24 | $0.38 | $0.40 | ||
| Q3 24 | $0.23 | $0.41 | ||
| Q2 24 | $0.31 | $-0.09 | ||
| Q1 24 | $0.30 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $97.5M |
| Total DebtLower is stronger | $86.7M | $22.7M |
| Stockholders' EquityBook value | $485.7M | $130.3M |
| Total Assets | $5.2B | $216.3M |
| Debt / EquityLower = less leverage | 0.18× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
| Q4 25 | $86.7M | $22.7M | ||
| Q3 25 | $86.6M | $34.0M | ||
| Q2 25 | $86.4M | $45.3M | ||
| Q1 25 | $86.3M | $56.7M | ||
| Q4 24 | $86.2M | $68.0M | ||
| Q3 24 | $86.0M | $79.3M | ||
| Q2 24 | $88.9M | $90.7M | ||
| Q1 24 | $88.8M | $102.0M |
| Q4 25 | $485.7M | $130.3M | ||
| Q3 25 | $465.9M | $115.3M | ||
| Q2 25 | $437.7M | $104.7M | ||
| Q1 25 | $429.1M | $97.1M | ||
| Q4 24 | $406.0M | $92.1M | ||
| Q3 24 | $439.7M | $71.1M | ||
| Q2 24 | $396.7M | $48.5M | ||
| Q1 24 | $397.0M | $51.0M |
| Q4 25 | $5.2B | $216.3M | ||
| Q3 25 | $5.2B | $202.9M | ||
| Q2 25 | $5.2B | $194.9M | ||
| Q1 25 | $5.2B | $196.2M | ||
| Q4 24 | $5.1B | $213.3M | ||
| Q3 24 | $5.2B | $220.7M | ||
| Q2 24 | $5.2B | $205.0M | ||
| Q1 24 | $5.1B | $214.1M |
| Q4 25 | 0.18× | 0.17× | ||
| Q3 25 | 0.19× | 0.30× | ||
| Q2 25 | 0.20× | 0.43× | ||
| Q1 25 | 0.20× | 0.58× | ||
| Q4 24 | 0.21× | 0.74× | ||
| Q3 24 | 0.20× | 1.12× | ||
| Q2 24 | 0.22× | 1.87× | ||
| Q1 24 | 0.22× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $60.0M | $14.4M |
| Free Cash FlowOCF − Capex | $52.2M | $14.4M |
| FCF MarginFCF / Revenue | 73.0% | 19.1% |
| Capex IntensityCapex / Revenue | 11.0% | 0.0% |
| Cash ConversionOCF / Net Profit | 4.10× | — |
| TTM Free Cash FlowTrailing 4 quarters | $85.8M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.0M | $14.4M | ||
| Q3 25 | $10.7M | $9.7M | ||
| Q2 25 | $14.0M | $14.1M | ||
| Q1 25 | $15.7M | $3.6M | ||
| Q4 24 | $66.6M | $15.6M | ||
| Q3 24 | $23.9M | $11.0M | ||
| Q2 24 | $16.6M | $1.0M | ||
| Q1 24 | $13.7M | $11.2M |
| Q4 25 | $52.2M | $14.4M | ||
| Q3 25 | $9.0M | $9.7M | ||
| Q2 25 | $12.4M | $14.1M | ||
| Q1 25 | $12.2M | $3.6M | ||
| Q4 24 | $54.9M | $15.6M | ||
| Q3 24 | $20.4M | $11.0M | ||
| Q2 24 | $14.4M | $1.0M | ||
| Q1 24 | $12.2M | — |
| Q4 25 | 73.0% | 19.1% | ||
| Q3 25 | 12.8% | 17.7% | ||
| Q2 25 | 17.8% | 26.8% | ||
| Q1 25 | 18.0% | 7.7% | ||
| Q4 24 | 79.2% | 26.4% | ||
| Q3 24 | 29.1% | 13.7% | ||
| Q2 24 | 21.6% | 2.1% | ||
| Q1 24 | 19.2% | — |
| Q4 25 | 11.0% | 0.0% | ||
| Q3 25 | 2.4% | 0.0% | ||
| Q2 25 | 2.3% | 0.0% | ||
| Q1 25 | 5.2% | 0.1% | ||
| Q4 24 | 16.9% | 0.0% | ||
| Q3 24 | 4.9% | 0.0% | ||
| Q2 24 | 3.3% | 0.0% | ||
| Q1 24 | 2.4% | 0.0% |
| Q4 25 | 4.10× | — | ||
| Q3 25 | 0.86× | 1.10× | ||
| Q2 25 | 1.01× | 2.41× | ||
| Q1 25 | 1.15× | 1.21× | ||
| Q4 24 | 4.63× | — | ||
| Q3 24 | 2.80× | 0.54× | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | 1.22× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
